article thumbnail

This Common Artificial Sweetener Can Break Down DNA, Scientists Warn

AuroBlog - Aurous Healthcare Clinical Trials blog

According to a new study, it’s also capable of damaging the DNA material inside our cells. As DNA holds the genetic code controlling how our bodies grow and are maintained, that’s a serious problem that […]

DNA 240
article thumbnail

These DNA-Damaging Molecules May Be The Link Between Colon Cancer And IBD

AuroBlog - Aurous Healthcare Clinical Trials blog

Scientists have discovered DNA-damaging molecules made by gut bacteria that may help explain why people with inflammatory bowel disease (IBD) have higher rates of colorectal cancer than those without the condition.

DNA 240
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A new startup from Feng Zhang and an ex-Illumina executive zeroes in on the epigenome

Bio Pharma Dive

Moonwalk Biosciences, the latest biotech cofounded by the gene editing scientist, joins other startups aiming to alter gene expression without changing DNA.

article thumbnail

Tome Biosciences debuts with $213M and a new way to edit the genome

Bio Pharma Dive

Based on the work of MIT scientists, the well-funded startup is developing ways to insert large sizes of genetic material anywhere in the genome without damaging or breaking DNA.

Genome 334
article thumbnail

UK scientists say they have found cancer driver in junk DNA

pharmaphorum

It has suspected for many years that some diseases may be linked to non-coding or ‘junk’ DNA, but the mechanism behind the pathology hasn’t been worked out. Now, scientists in the UK think they have found a culprit implicated in cancer.

DNA 116
article thumbnail

Gladstone and UCSF scientists discover BET protein role in Covid-19

Pharmaceutical Technology

A close look at the virus also showed that the envelope protein has a small region that looks like human histones, which are protein complexes seen along DNA. The post Gladstone and UCSF scientists discover BET protein role in Covid-19 appeared first on Pharmaceutical Technology.

Protein 278
article thumbnail

Mitochondrial drugs, with a twist: Pretzel Therapeutics launches with $72.5M in funding

Bio Pharma Dive

Scientists at Pretzel believe fixing mutated mitochondrial DNA with a mix of small molecule therapies and gene editing could be key to solving a number of hard-to-treat diseases.